Epidemiology Consulting for Digital Health & AI: RWE, Validation Studies, and FDA-Ready Evidence

In the race to revolutionize healthcare, Digital Health and AI Health companies are redefining how we detect, monitor, and manage disease. From predictive algorithms to virtual care platforms and AI-powered diagnostics, these innovations promise to transform clinical care. But one challenge continues to separate visionary tech from clinical credibility: the need for rigorous evidence.

Why Digital Health Startups Need Epidemiology Consulting

Investors, regulators, and payers want proof that your solution works—not just promising demos. Epidemiology helps you:

  • Design FDA-aligned real-world studies
  • Validate AI model performance in clinical populations
  • Demonstrate generalizability, fairness, and outcomes impact
  • Support publications, grant funding, and payer value discussions

Real-World Evidence (RWE) Design for Digital Health

We design retrospective cohort studies, case-control analyses, and pragmatic trials that generate regulatory-grade RWE—using EHRs, claims data, or platform-based analytics.

AI Model Validation and Subgroup Analysis in Health Tech

We evaluate your AI’s generalizability and performance across populations with subgroup analysis, calibration metrics, and transparent reporting frameworks.

Protocol Design and FDA Strategy

We help you prepare robust, credible protocols that meet FDA, payer, and partner expectations—streamlining validation and regulatory alignment.

Publication and Evidence Communications

We support manuscript drafting, journal submission, and conference preparation—turning your data into publishable clinical impact stories.

Partner with BioEpiNet for Epidemiology Consulting

Your product may be brilliant—but without evidence, it won’t scale. Let’s validate your work with strategy, science, and speed. Learn more about our epidemiology consulting services.

Contact BioEpiNet:
📞 (312) 709‑7336
🌐 www.bioepinet.com
📧 [email protected]
👉 Schedule a consultation

Epidemiology Consulting Services for Pharma & Biotech: Real-World Evidence, Study Design, and Publication Support

In a world where data drives approvals, partnerships, and payer access, mid-size pharmaceutical and biotech companies are under increasing pressure to generate robust, defensible, and publication-ready evidence—without the resources of Big Pharma.

You may be advancing a first-in-class therapeutic, leading a promising post-marketing program, or preparing to submit to regulators. Yet you face real constraints: lean internal teams, tight timelines, and complex demands from regulators, payers, and investors alike.

Why Mid-size Pharmaceutical Companies Need Epidemiology Consulting

Mid-size firms are the engine of innovation in life sciences. But they are being asked to deliver more, with less:

How BioEpiNet Adds Strategic Value

We plug into your existing Medical Affairs, RWE, or Clinical teams as your expert epidemiology partner:

1. Real-World Evidence Generation

We design and analyze studies that meet FDA/EMA standards for post-marketing surveillance, label expansion, and comparative effectiveness.

2. Systematic Literature Reviews (SLRs)

We deliver rapid, PRISMA-compliant literature reviews and evidence gap analyses to support market access and regulatory submissions.

3. Protocol & Statistical Analysis Plan (SAP) Development

We draft and refine protocols and SAPs to support registries, Phase IV studies, and investigator-led RWE programs.

4. Post-marketing Study Design & Safety Analytics

We support PSURs, signal detection, and RMPs with statistically sound observational methods.

5. Manuscript & Scientific Communication Support

From journal submissions to conference abstracts, we help transform your evidence into compelling, publication-ready outputs.

Real-World Examples of Our Impact

  • RWE study for label expansion in cardio-renal drug class
  • Meta-analysis of real-world safety data for CNS pipeline
  • Protocol & SAP development for oncology registry
  • SLR and value narrative for rare disease market access

Contact BioEpiNet for Epidemiology Consulting

If you’re preparing for your next submission, payer conversation, or evidence milestone, partner with BioEpiNet—your trusted epidemiology and biostatistics resource for pharma and biotech.

BioEpiNet
Based in Chicago — Serving clients nationwide
📞 (312) 709‑7336
🌐 www.bioepinet.com
📧 [email protected]
👉 Schedule a consultation

Machine Learning Consulting for Healthcare & Research: Model Design, Validation & Deployment

As healthcare embraces AI and machine learning, effective and trusted model development becomes essential. At BioEpiNet, our ML consulting goes beyond algorithms—it integrates clinical insight, epidemiologic rigor, and deployment strategy to build models that perform reliably, ethically, and in real-world settings.

Why Machine Learning in Healthcare Needs Expert Guidance

  • Clinical validity: Models must work across diverse patient populations and settings
  • Regulatory scrutiny: FDA expectations for algorithm transparency and validation are increasing
  • Publication readiness: Journals now expect clear methodology and reproducibility (e.g., in bioinformatics)
  • Deployment complexity: Integration into workflows demands robust testing and monitoring

How BioEpiNet Supports Your ML Journey

Our team bridges domain expertise and advanced methods. We help with:

1. Model Selection & Development

Choose the right algorithm—whether random forests, neural networks, or support vector machines—based on data structure, clinical context, and predictive goals. We follow best practices in reproducible data pipelines and feature engineering.

2. Validation, Bias, and Generalizability

We perform:

  • Cross-validation and holdout testing
  • Subgroup performance and fairness assessments
  • Calibration analysis using clinical benchmarks

3. Regulatory & Clinical Alignment

Our protocols align with FDA guidance for digital health tools and AI, ensuring transparency and readiness for deployment. We help you prepare Pre-Sub meeting materials or technical validation documents.

4. Deployment Strategy & Monitoring

We guide real-world implementation with:

  • Human-in-the-loop pilot studies
  • Monitoring pipelines for drift and performance decay
  • Clinical partnerships and stakeholder feedback loops

5. Publication & Funding Support

From drafting Methods sections to preparing figures and writing grant components, we help translate your ML insights into high-impact manuscripts, funding proposals, or white papers.

Who Should Work with Us?

  • Digital Health & AI startups building diagnostic tools
  • Health systems & EHR platforms seeking clinical insights
  • Pharma & biotech using ML for RWE, biomarker development, or predictive safety models
  • Academics & CROs developing translational ML research or pilot actionable algorithms

ML Use Cases We’ve Supported

  • Cardiovascular risk model validation on EHR datasets
  • Clinical outcome classifier for ICU patient triage
  • Genomic subtype prediction using neural nets and ML interpretability
  • Workflow-integrated AI tool for remote patient monitoring

At BioEpiNet, our Machine Learning consulting is powered by a multidisciplinary team of PhD data scientists, biostatisticians, epidemiologists, and MD-clinicians. This unique blend of technical and clinical expertise ensures that every model we help build is not only algorithmically sound, but also scientifically valid, clinically meaningful, and aligned with regulatory and ethical standards.

Learn more about our ML services: Machine Learning Consulting

Ready to Build Trusted ML in Healthcare?

Contact BioEpiNet and let’s discuss your vision—whether it’s a pilot validation study, FDA readiness plan, or publication strategy.

Contact Us:
📞 (312) 709‑7736
🌐 www.bioepinet.com
📧 [email protected]
👉 Schedule a free consultation

Biostatistical Consulting: Why Expert Statistical Support is Critical to Research Success

In today’s evidence-driven world, biostatistics is not just a technical skill—it’s the backbone of credible science. Whether you’re a pharma company preparing a regulatory submission, a digital health firm validating a clinical algorithm, or a researcher designing a trial, the quality of your statistics can make or break your project.

That’s why organizations across life sciences and healthcare turn to biostatistical consulting firms like BioEpiNet—to get expert guidance, minimize errors, and produce defensible, publication-ready results.

What is Biostatistical Consulting?

Biostatistical consulting applies advanced statistical methods to solve complex problems in health research. It ensures:

Who Needs Biostatistics Consulting?

  • Pharma & Biotech – for clinical trial design, SAPs, interim analyses, and regulatory submissions
  • Digital Health & AI Companies – to validate models and support FDA readiness
  • Academic Researchers – for grant proposals and publication support
  • HEOR & Medical Affairs – to support real-world evidence and value demonstration
  • Startups & CROs – needing expert statistics without full-time staff

What BioEpiNet Offers

1. Study Design & Sample Size Estimation

We support protocols, endpoint strategy, and power calculations for clinical and observational studies. Visit our services page for more.

2. Statistical Analysis Plan (SAP) Development

We write regulatory-grade SAPs aligned with CDISC SDTM and FDA guidance.

3. Advanced Statistical Modeling

We apply time-to-event, GLM, GEE, mixed-effects, Bayesian models, and causal inference techniques tailored to your study. For methods like GEE, we ensure proper model assumptions are met.

4. Data Analysis & Interpretation

We deliver clean, reproducible code in R, SAS, or Python with clear narrative reporting for clinical and regulatory audiences.

5. Manuscript & Submission Support

We help you publish your results or prepare regulatory briefing books with concise statistical methods and clear figures/tables. For manuscript transparency, we follow CONSORT reporting standards.

Use Cases We’ve Supported

  • Power and SAP development for a Phase II oncology trial
  • Longitudinal PRO modeling in a DTx study
  • Validation of a cardiovascular risk prediction model
  • RWE safety data analysis for rare disease registry
  • Co-authoring statistical methods for peer-reviewed publications

Why Clients Choose BioEpiNet

  • PhD-level biostatisticians and MD epidemiologists
  • Fast turnaround and high responsiveness
  • Confidential, compliant, and publication-ready
  • Flexible pricing and scoped engagements
  • Clear statistical narratives for diverse audiences

Contact BioEpiNet for Biostatistical Consulting

Whether you’re preparing a study, regulatory package, or publication, BioEpiNet delivers expert statistical consulting with strategic insight. Learn more about our biostatistics support services.

Contact Us:
📞 (312) 709‑7336
🌐 www.bioepinet.com
📧 [email protected]
👉 Request a free consultation